Nom du produit:4-[2-[2-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethylamino]-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione

IUPAC Name:4-(18-azido-4,7,10,13,16-pentaoxa-1-azaoctadecan-1-yl)-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione

CAS:2624181-61-7
Formule moléculaire:C25H34N6O9
Pureté:97%
Numéro de catalogue:CM1076073
Poids moléculaire:562.58

Unité d'emballage Stock disponible Prix($) Quantité
CM1076073-100mg in stock ƿŵŵ
CM1076073-250mg in stock ȡƿŵ
CM1076073-500mg in stock ũƥǜ
CM1076073-1g in stock ƛƥǶȐ
CM1076073-5g in stock Ȑƛǜƥ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:2624181-61-7
Formule moléculaire:C25H34N6O9
Point de fusion:-
Code SMILES:[N-]=[N+]=NCCOCCOCCOCCOCCOCCNC1=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=CC=C1
Densité:
Numéro de catalogue:CM1076073
Poids moléculaire:562.58
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.